je.st
news
Tag: pfizer
Pfizer and Merck to Collaborate on Study Evaluating Novel Anti-Cancer Combination Regimen
2014-08-26 16:20:33| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Agreement to Combine Mercks Investigational Anti-PD-1 Antibody Pembrolizumab and Pfizers crizotinib (XALKORI) in Clinical Trial WHITEHOUSE STATION, N.J. Pfizer Inc. (NYSE:PFE) and Merck & Co. Inc. (NYSE: MRK), known as MSD outside the United States and Canada, through a subsidiary, announced today that they have entered into an agreement to explore the therapeutic potential of the combination of Pfizers crizotinib (XALKORI) with Mercks investigational anti-PD-1 antibody pembrolizumab, in a Phase 1b clinical study evaluating the safety and tolerability of the combination in patients with ALK-positive advanced or metastatic non-small cell lung cancer (NSCLC). Language: English read more
Tags: study
combination
evaluating
collaborate
Pfizer back for AstraZeneca? Year-end move seen most likely
2014-08-21 16:38:26| Biotech - Topix.net
Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion takeover attempt in May. But while British takeover rules mean deal talks could be back on the cards as early as Aug. 26, following the ending of the first of a two-stage ... (more)
23andMe, Pfizer partner to explore genetic factors associated with IBD
2014-08-12 20:38:33| Biotech - Topix.net
Approximately 1.4 million people in the U.S. alone suffer from IBD, according to estimates from the Centers for Disease Control and Prevention .
Tags: with
partner
factors
explore
23andMe will test DNA of 10,000 bowel disease patients in partnership with Pfizer
2014-08-12 19:33:44| Biotech - Topix.net
Pfizer Inc. is teaming up with DNA testing company 23andMe to study the possible genetic underpinnings of inflammatory bowel disease, a hard-to-treat ailment that affects an estimated 1.4 million Americans.
Tags: with
test
partnership
disease
Pfizer, 23andMe team up to study bowel disease
2014-08-12 17:23:54| Biotech - Topix.net
Under the partnership, 23andMe will map the DNA of 10,000 patients who have forms of the disease, which include Crohn's disease and ulcerative colitis.
Tags: team
study
disease
bowel
Sites : [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] next »